Translational Research
Volume 156, Issue 2 , Pages 68-79 , August 2010

Initial burst of viremia related to CD8 effector memory T cells after living donor liver transplantation in hepatitis C virus-infected recipients

  • Yasutsugu Takada

      Affiliations

    • Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • ,
  • Kazue Ozawa

      Affiliations

    • Hepatic Disease Research Institute, Kyoto University Hospital, Kyoto, Japan
    • Corresponding Author InformationReprint requests: Kazue Ozawa, Hepatic Disease Research Institute, Honmachi-15chyome-754-1, Higashiyama-ku, Kyoto 605-0981, Japan
  • ,
  • Hiroto Egawa

      Affiliations

    • Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • ,
  • Satoshi Teramukai

      Affiliations

    • Division of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto, Japan
  • ,
  • Akira Mori

      Affiliations

    • Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • ,
  • Toshimi Kaido

      Affiliations

    • Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • ,
  • Mureo Kasahara

      Affiliations

    • Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • ,
  • Kohei Ogawa

      Affiliations

    • Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • ,
  • Masako Ono

      Affiliations

    • Hepatic Disease Research Institute, Kyoto University Hospital, Kyoto, Japan
  • ,
  • Hiroshi Sato

      Affiliations

    • Division of Bioscience, Shiga University of Medical Science, Shiga, Japan
  • ,
  • Koichi Tanaka

      Affiliations

    • Institute of Biomedical Research and Innovation, Hyogo, Japan
  • ,
  • Shinji Uemoto

      Affiliations

    • Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Received 18 November 2009 ,Revised 6 June 2010 ,Accepted 8 June 2010.

References 

  1. Ballardini G, De Raffele E, Groff P, et al. Timing of reinfection and mechanisms of hepatocelluar damage in transplanted hepatitis C virus-reinfected liver. Liver Transpl. 2002;8:10–20
  2. Chazouilleres O, Kim M, Combs C, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology. 1994;106:994–999
  3. Charlton M. Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence. Liver Transpl. 2003;9:S58–S62
  4. Charlton M, Seaberg E, Wiesner R, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 998;28:823–30.
  5. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996;334:815–820
  6. Berenguer M, Prieto M, Rayón JM, et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology. 2000;32:852–858
  7. Champagne P, Ogg GS, King AS, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 2001;410:106–111
  8. Appay V, Dunbar PR, Callan M, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8:379–385
  9. Altman JD, Moss PA, Goulder PJ, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274:94–96
  10. Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ. Rapid effector function in CD8+ memory T cells. J Exp Med. 1997;186:859–865
  11. Waldrop SL, Pitcher CJ, Peterson DM, Maino VC, Picker LJ. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest. 1997;99:1739–1750
  12. Belz GT, Xie W, Altman JD, Doherty PC. A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge. J Virol. 2000;74:3486–3493
  13. Stevenson PG, Belz GT, Altman JD, Doherty PC. Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection. Eur J Immunol. 1999;29:1059–1067
  14. Murali-Krishna K, Altman JD, Suresh M, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 1998;8:177–187
  15. Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB. Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med. 2002;195:893–905
  16. Wong P, Pamer EG. CD8 T cell responses to infectious pathogens. Annu Rev Immunol. 2003;21:29–70
  17. Maloy KJ, Burkhart C, Freer G, et al. Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection. J Immunol. 1999;162:2867–2874
  18. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature. 2003;421:852–856
  19. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 2003;300:337–339
  20. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 2003;300:339–342
  21. Khanolkar A, Fuller MJ, Zajac AJ. CD4 T cell-dependent CD8 T cell maturation. J Immunol. 2004;172:2834–2844
  22. Tanaka K, Inomata Y, Kaihara S. Living-donor liver transplantation, surgical techniques and innovation. Barcelona, Spain: Prous Science; 2003;
  23. Egawa H, Uemoto S, Takada Y, et al. Initial steroid bolus injection promotes vigorous CD8+ alloreactive responses toward early graft acceptance immediately after liver transplantation in humans. Liver Transpl. 2007;13:1262–1271
  24. Tanaka K, Ozawa K, Teramukai S, et al. Classification of human liver transplant recipients by the preoperative CD8+ T cell subpopulation and its relation to outcome. Liver Transpl. 2006;12:792–800
  25. Egawa H, Ohmori K, Haga H, et al. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transpl. 2007;13:579–588
  26. Ohno O, Mizokami M, Wu RR, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol. 1997;35:201–207
  27. Uemoto S, Ozawa K, Egawa H, et al. Serial assessment of immune status by circulating CD8+ effector T cell frequencies for posttransplant infectious complications. Clin Dev Immunol. 2008;2008:718386
  28. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289–293
  29. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825–832
  30. Everitt BS, Landau S, Leese M. Hierarchial clustering. In:  Everitt BS,  Landau S,  Leese M editor. Cluster analysis. 4th ed. London, UK: Arnold; 2001;p. 55–89
  31. Yu AS, Ahmed A, Keeffe EB. Liver transplantation: evolving patient selection criteria. Can J Gastroenterol. 2001;15:729–738
  32. Fearon DT. The expansion and maintenance of antigen-selected CD8+ T cell clones. In: Advances in immunology. Atlanta, GA: Elsevier; 2007;
  33. Fearon DT, Carr JM, Telaranta A, Carrasco MJ, Thaventhiran JE. The rationale for the IL-2-independent generation of the self-renewing central memory CD8+ T cells. Immunol Rev. 2006;211:104–118
  34. Egawa H, Ozawa K, Takada Y, et al. Coupled regulation of interleukin-12 receptor beta-1 of CD8+ central memory and CCR7-negative memory T cells in an early alloimmunity in liver transplant recipients. Clin Exp Immunol. 2010;160:420–430
  35. Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest. 2003;111:1887–1895
  36. Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol. 2002;2:417–426
  37. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. Visualizing the generation of memory CD4 T cells in the whole body. Nature. 2001;410:101–105
  38. Jenkins MK, Khoruts A, Ingulli E, et al. In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol. 2001;19:23–45
  39. Rosen HR. Hepatitis C virus in the human liver transplantation model. Clin Liver Dis. 2003;7:107–125
  40. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest. 1996;98:1432–1440
  41. Bowen DG, Walker CM. The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection?. J Hepatol. 2005;42:408–417
  42. Gruener NH, Jung MC, Ulsenheimer A, et al. Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation. Liver Transpl. 2004;10:1487–1496
  43. Ciuffreda D, Comte D, Cavassini M, et al. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol. 2008;38:2665–2677
  44. Carpentier A, Conti F, Stenard F, et al. Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation. Am J Transplant. 2009;9:2102–2112
  45. Rosen HR, Hinrichs DJ, Leistikow RL, et al. Cutting edge: identification of hepatitis C virus-specific CD8+ T cells restricted by donor HLA alleles following liver transplantation. J Immunol. 2004;173:5355–5359

 Supported by grants 13204041, 13307038, 15390394, and 19390332 from the Scientific Research Fund of the Ministry of Education, Science, and Culture of Japan.

PII: S1931-5244(10)00117-9

doi: 10.1016/j.trsl.2010.06.002

Translational Research
Volume 156, Issue 2 , Pages 68-79 , August 2010